SPY336.84+0.01 0.00%
DIA279.80+0.38 0.14%
IXIC11,019.30-23.20 -0.21%

H.C. Wainwright Downgrades EyePoint Pharmaceuticals to Neutral

H.C. Wainwright downgrades EyePoint Pharmaceuticals (NASDAQ:EYPT) from Buy to Neutral.

Benzinga · -

H.C. Wainwright downgrades EyePoint Pharmaceuticals (NASDAQ:EYPT) from Buy to Neutral.